This suggests that the scarcity of PTPRD and WWOX genes might have played an important role in progression of HNSCC, and could be considered as a target for cancer therapy or a biomarker in molecular pathology. The gene discussed is WWOX; the disease is head and neck squamous cell carcinoma.